Capital Research Global Investors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.29M | Buy |
62,629
+5,099
| +9% | +$349K | ﹤0.01% | 416 |
|
|
2025
Q1 | $3.99M | Buy |
57,530
+9,280
| +19% | +$643K | ﹤0.01% | 438 |
|
|
2024
Q4 | $4.14M | Sell |
48,250
-6,636
| -12% | -$569K | ﹤0.01% | 423 |
|
|
2024
Q3 | $6.63M | Buy |
54,886
+4,669
| +9% | +$564K | ﹤0.01% | 398 |
|
|
2024
Q2 | $7.26M | Buy |
50,217
+2,984
| +6% | +$431K | ﹤0.01% | 394 |
|
|
2024
Q1 | $6.06M | Buy |
47,233
+13,181
| +39% | +$1.69M | ﹤0.01% | 397 |
|
|
2023
Q4 | $3.52M | Buy |
34,052
+407
| +1% | +$42.1K | ﹤0.01% | 396 |
|
|
2023
Q3 | $3.08M | Buy |
33,645
+1,111
| +3% | +$102K | ﹤0.01% | 401 |
|
|
2023
Q2 | $2.55M | Buy |
32,534
+506
| +2% | +$39.7K | ﹤0.01% | 407 |
|
|
2023
Q1 | $2.53M | Sell |
32,028
-12,224
| -28% | -$966K | ﹤0.01% | 416 |
|
|
2022
Q4 | $2.99M | Buy |
+44,252
| New | +$2.99M | ﹤0.01% | 422 |
|
|
2018
Q3 | – | Sell |
-22
| Closed | -$1K | – | 460 |
|
|
2018
Q2 | $1K | Sell |
22
-2
| -8% | -$91 | ﹤0.01% | 433 |
|
|
2018
Q1 | $1K | Buy |
24
+14
| +140% | +$583 | ﹤0.01% | 435 |
|
|
2017
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 439 |
|
|
2017
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 438 |
|